Lipoic acid for neuroprotection in secondary progressive multiple sclerosis: Results of a randomised placebo-controlled pilot trial

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: 074aaffb46882664253af5771bf2adca169862a8
First added on: Apr 29, 2026